What's breaking now, across thousands of outlets.
Superluminal Medicines banked $60 million in funding to support development of a drug designed to work similarly to — but potentially be more selectively than — Rhythm Pharmaceuticals’ marketed medicine Imcivree.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Nvidia agreed to acquire artificial intelligence platform Hugging Face for $12.9 billion, according to a Thursday (Sept. 3) company blog post by Founder and CEO Jensen Huang.
Engineering teams adopting the AI-Driven Development Lifecycle (AI-DLC) often struggle to turn concepts into working code.
Happy Janmashtami: Celebrated this Janmashtami by sending pictures and greetings to your friends, family and loved ones. Use these prompts create fun Krishna and Radha Rani-themed wishes.
An AI agent doesn’t need to be malicious to cause damage. It just needs to reason its way into the wrong system, the way a well-meaning agent handling a finance report might decide it needs a code…
Jensen Huang, CEO of Nvidia, said the acquisition aimed to provide more "open weights to the AI economy" and promised not to impose requirements to use Nvidia technology on the platform.
